Christian T Farrar1, Danielle K DePeralta2, Helen Day1, Tyson A Rietz1, Lan Wei2, Gregory Y Lauwers3, Boris Keil1, Arun Subramaniam4, Anthony J Sinskey5, Kenneth K Tanabe2, Bryan C Fuchs6, Peter Caravan7. 1. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 149 Thirteenth St., Suite 2301, Charlestown, MA 02129, United States. 2. Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, WRN 401, 55 Fruit St., Boston, MA 02114, United States. 3. Pathology, Massachusetts General Hospital and Harvard Medical School, WRN 2, 55 Fruit St., Boston, MA 02114, United States. 4. Sanofi Genzyme, 49 New York Ave, Framingham, MA 01701, United States. 5. Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, MA 02139, United States. 6. Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, WRN 401, 55 Fruit St., Boston, MA 02114, United States. Electronic address: bfuchs@mgh.harvard.edu. 7. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 149 Thirteenth St., Suite 2301, Charlestown, MA 02129, United States. Electronic address: caravan@nmr.mgh.harvard.edu.
Abstract
BACKGROUND & AIMS: Liver biopsy, the gold standard for assessing liver fibrosis, suffers from limitations due to sampling error and invasiveness. There is therefore a critical need for methods to non-invasively quantify fibrosis throughout the entire liver. The goal of this study was to use molecular Magnetic Resonance Imaging (MRI) of Type I collagen to non-invasively image liver fibrosis and assess response to rapamycin therapy. METHODS: Liver fibrosis was induced in rats by bile duct ligation (BDL). MRI was performed 4, 10, or 18 days following BDL. Some BDL rats were treated daily with rapamycin starting on day 4 and imaged on day 18. A three-dimensional (3D) inversion recovery MRI sequence was used to quantify the change in liver longitudinal relaxation rate (ΔR1) induced by the collagen-targeted probe EP-3533. Liver tissue was subjected to pathologic scoring of fibrosis and analyzed for Sirius Red staining and hydroxyproline content. RESULTS: ΔR1 increased significantly with time following BDL compared to controls in agreement with ex vivo measures of increasing fibrosis. Receiver operating characteristic curve analysis demonstrated the ability of ΔR1 to detect liver fibrosis and distinguish intermediate and late stages of fibrosis. EP-3533 MRI correctly characterized the response to rapamycin in 11 out of 12 treated rats compared to the standard of collagen proportional area (CPA). 3D MRI enabled characterization of disease heterogeneity throughout the whole liver. CONCLUSIONS: EP-3533 allowed for staging of liver fibrosis, assessment of response to rapamycin therapy, and demonstrated the ability to detect heterogeneity in liver fibrosis.
BACKGROUND & AIMS: Liver biopsy, the gold standard for assessing liver fibrosis, suffers from limitations due to sampling error and invasiveness. There is therefore a critical need for methods to non-invasively quantify fibrosis throughout the entire liver. The goal of this study was to use molecular Magnetic Resonance Imaging (MRI) of Type I collagen to non-invasively image liver fibrosis and assess response to rapamycin therapy. METHODS:Liver fibrosis was induced in rats by bile duct ligation (BDL). MRI was performed 4, 10, or 18 days following BDL. Some BDL rats were treated daily with rapamycin starting on day 4 and imaged on day 18. A three-dimensional (3D) inversion recovery MRI sequence was used to quantify the change in liver longitudinal relaxation rate (ΔR1) induced by the collagen-targeted probe EP-3533. Liver tissue was subjected to pathologic scoring of fibrosis and analyzed for Sirius Red staining and hydroxyproline content. RESULTS: ΔR1 increased significantly with time following BDL compared to controls in agreement with ex vivo measures of increasing fibrosis. Receiver operating characteristic curve analysis demonstrated the ability of ΔR1 to detect liver fibrosis and distinguish intermediate and late stages of fibrosis. EP-3533 MRI correctly characterized the response to rapamycin in 11 out of 12 treated rats compared to the standard of collagen proportional area (CPA). 3D MRI enabled characterization of disease heterogeneity throughout the whole liver. CONCLUSIONS:EP-3533 allowed for staging of liver fibrosis, assessment of response to rapamycin therapy, and demonstrated the ability to detect heterogeneity in liver fibrosis.
Authors: Jayant A Talwalkar; Meng Yin; Jeff L Fidler; Schuyler O Sanderson; Patrick S Kamath; Richard L Ehman Journal: Hepatology Date: 2008-01 Impact factor: 17.425
Authors: Patrick A Helm; Peter Caravan; Brent A French; Vincent Jacques; Luhua Shen; Yaqin Xu; Ronald J Beyers; R Jack Roy; Christopher M Kramer; Frederick H Epstein Journal: Radiology Date: 2008-04-10 Impact factor: 11.105
Authors: Pauline Désogère; Luis F Tapias; Tyson A Rietz; Nicholas Rotile; Francesco Blasi; Helen Day; Justin Elliott; Bryan C Fuchs; Michael Lanuti; Peter Caravan Journal: J Nucl Med Date: 2017-06-13 Impact factor: 10.057
Authors: Cindy X Cai; Hema Buddha; Shobha Castelino-Prabhu; Zhiwei Zhang; Robert S Britton; Bruce R Bacon; Brent A Neuschwander-Tetri Journal: Dig Dis Sci Date: 2017-02-13 Impact factor: 3.199
Authors: Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller Journal: Abdom Radiol (NY) Date: 2017-08
Authors: Iris Y Zhou; Veronica Clavijo Jordan; Nicholas J Rotile; Eman Akam; Smitha Krishnan; Gunisha Arora; Hema Krishnan; Hannah Slattery; Noah Warner; Nathaniel Mercaldo; Christian T Farrar; Jeremy Wellen; Robert Martinez; Franklin Schlerman; Kenneth K Tanabe; Bryan C Fuchs; Peter Caravan Journal: Radiology Date: 2020-04-28 Impact factor: 11.105
Authors: Bo Zhu; Lan Wei; Nicholas Rotile; Helen Day; Tyson Rietz; Christian T Farrar; Gregory Y Lauwers; Kenneth K Tanabe; Bruce Rosen; Bryan C Fuchs; Peter Caravan Journal: Hepatology Date: 2016-12-31 Impact factor: 17.425
Authors: Christian T Farrar; Eric M Gale; Richard Kennan; Ian Ramsay; Ricard Masia; Gunisha Arora; Kailyn Looby; Lan Wei; Jayashree Kalpathy-Cramer; Michelle M Bunzel; Chunlian Zhang; Yonghua Zhu; Taro E Akiyama; Michael Klimas; Shirly Pinto; Himashinie Diyabalanage; Kenneth K Tanabe; Valerie Humblet; Bryan C Fuchs; Peter Caravan Journal: Radiology Date: 2017-11-20 Impact factor: 11.105